Cas:1007211-20-2 4-[(4-Bromo-3-fluorophenyl)sulfonyl]morpholine manufacturer & supplier

Chemical Name:4-[(4-Bromo-3-fluorophenyl)sulfonyl]morpholine

CAS.NO:1007211-20-2

Synonyms:4-[(4-Bromo-3-fluorophenyl)sulfonyl]morpholine;4-((4-bromo-3-fluorophenyl)sulfonyl)morpholine;Morpholine, 4-[(4-bromo-3-fluorophenyl)sulfonyl]-

Molecular Formula:C₁₀H₁₁BrFNO₃S

Molecular Weight:324.167

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:415.9±55.0 °C at 760 mmHg

Density:1.7±0.1 g/cm3

Index of Refraction:1.582

PSA:54.99000

Exact Mass:322.962708

LogP:2.43

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-[(4-Bromo-3-fluorophenyl)sulfonyl]morpholine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Morpholine, 4-[(4-bromo-3-fluorophenyl)sulfonyl]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Morpholine, 4-[(4-bromo-3-fluorophenyl)sulfonyl]- Use and application,4-((4-bromo-3-fluorophenyl)sulfonyl)morpholine technical grade,usp/ep/jp grade.

Related News: In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank. 4-[(4-Bromo-3-fluorophenyl)sulfonyl]morpholine manufacturer In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank. 4-[(4-Bromo-3-fluorophenyl)sulfonyl]morpholine supplier With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. 4-[(4-Bromo-3-fluorophenyl)sulfonyl]morpholine vendor Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. 4-[(4-Bromo-3-fluorophenyl)sulfonyl]morpholine factory With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.